Your browser doesn't support javascript.
loading
Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma.
Enßle, Julius C; Campe, Julia; Schwenger, Amelie; Wiercinska, Eliza; Hellstern, Helen; Dürrwald, Ralf; Rieger, Michael A; Wolf, Sebastian; Ballo, Olivier; Steffen, Björn; Serve, Hubert; Bonig, Halvard; Rabenau, Holger F; Widera, Marek; Ciesek, Sandra; Metzler, Ivana von; Ullrich, Evelyn.
Afiliación
  • Enßle JC; Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Campe J; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
  • Schwenger A; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Wiercinska E; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hellstern H; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
  • Dürrwald R; Experimental Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Rieger MA; Division of Pediatric Stem Cell Transplantation and Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Wolf S; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
  • Ballo O; Experimental Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Steffen B; Division of Pediatric Stem Cell Transplantation and Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Serve H; Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt am Main, Germany.
  • Bonig H; German Red Cross Blood Service BaWüHe, Frankfurt am Main, Germany.
  • Rabenau HF; Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt am Main, Germany.
  • Widera M; German Red Cross Blood Service BaWüHe, Frankfurt am Main, Germany.
  • Ciesek S; Robert Koch-Institut, Berlin, Germany.
  • Metzler IV; Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Ullrich E; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
Blood ; 139(1): 137-142, 2022 01 06.
Article en En | MEDLINE | ID: mdl-34657156
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / COVID-19 / Vacuna BNT162 / Mieloma Múltiple Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / COVID-19 / Vacuna BNT162 / Mieloma Múltiple Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos